Investigating the Central Sensitisation Inventory (CSI). Re-establishing clinically significant values to identify central sensitization.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON27116

Enrollment

1650

Registered

2021-01-28

Start date

2017-11-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic pain, central sensitization, pain rehabilitation, pelvic pain, back pain.

Interventions

Care as Usual for patients, not applicable for healty volunteers

Eligibility

Inclusion criteria

Inclusion criteria: Patients: - Patients who visited the UMCG pain center between November 1, 2017 and October 1, 2021 Healthy volunteers - Self-reported healthy and pain-free

Exclusion criteria

Exclusion criteria: Age younger than 18 years Healthy volunteers: - using pain medication - undergoing treatment for pain - reporting a CSS diagnosis in the CSI part B - reporting the use of antidepressants at moment of completing questionnaire - reporting the use of anti-epileptics at the moment of completing questionnaire

Design outcomes

Primary

Measure	Time frame
Central Sensitization Inventory	—

Contacts

Public ContactI. Schuttert

Universitair Medisch Centrum Groningen

i.schuttert@umcg.nl0651402937

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)